Search Videos and More
Video
Personalized Cancer Vaccine Helps Patient
Richard Boylan speaks out about his experience with a personalized kidney cancer vaccine, saying he's 'extraordinarily lucky.' He's part of a clinical trial at Dana-Farber Cancer Institute. His doctor, David Braun, MD, PhD, is one of the scientists leading the research.
News
Study Sounds Note of Caution on Effectiveness of COVID-19 Vaccines for Patients with Lymphoid Malignancies
Patients with lymphoma or other lymphoid cancers should continue to take steps to protect themselves from COVID-19 even if they have been vaccinated against the disease, a new study led by investigators at Dana-Farber Cancer Institute reports.
Video
COVID-19 and Cancer: Screenings Rebound but Study Finds Disparities
Cancer screenings rebounded after a dramatic decline in the first months of the COVID-19 pandemic, but a new study found an increase in disparities among some screening tests during the pandemic.
News
Vitamin D May Protect Against Young-Onset Colorectal Cancer
Consuming higher amounts of Vitamin D – mainly from dietary sources – may help protect against developing young-onset colorectal cancer or precancerous colon polyps, according to the first study to show such an association.
Podcast
Season 1, Episode 2: Behind the Science of the 2019 Nobel Prize
It’s hard to overstate just how important oxygen is to life on earth. Almost every living thing on the planet needs it to convert fuel into energy.
Podcast
Season 1, Episode 1: The Wolf in Sheep's Clothing
The parable of the wolf in sheep’s clothing tale reminds us that things aren’t always as they seem, that bad guys can dress up as good guys to do their bad guy things.
Video
Phenotype, Specificity and Avidity of Antitumour CD8+ T Cells in Melanoma
Dana-Farber's Giacomo Oliveira, PhD describes a study he led with Cathy Wu, MD, that appeared in Nature.
Video
Updated Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Clinical Trials
Sara Tolaney, MD, MPH discusses updated standardized definitions for efficacy endpoints in adjuvant breast cancer clinical trials: STEEP Version 2.0.
News
Study Pairs Two Forms of Immunotherapy in Patients with Advanced Kidney Cancer
T cells revved up to attack tumors are turned into an army of loiterers. Cells keenly attuned to signals of infection or disease fail to pick up the faint notes of cancer. A clinical trial led by Dana-Farber researchers is addressing both of these issues in patients who have undergone surgery for kidney cancer but have a high risk of recurrence.
News
Dana-Farber Cancer Institute Establishes the David Liposarcoma Research Initiative
Dana-Farber Cancer Institute announced that The Rossy Foundation has committed $10 million to establish the David Liposarcoma Research Initiative.
News
Study Reveals Factor That Determines ‘Fate’ of Cancer Cells When Tumor Suppressor Gene Function is Restored
Many cancers develop from cells that have a malfunctioning tumor suppressor gene, p53, which normally helps control unchecked cell growth and prevent cancer.
News
Cancer Screenings Rebounded in Late 2020 After COVID-related Decline, but Racial and Economic Disparities Remain for Some Tests
The numbers of cancer screening tests rebounded sharply in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic, at one large hospital system in the Northeastern United States. These findings were released in a study published in Cancer Cell. The research also found an increase in racial and socioeconomic disparities among users of some screening tests during the pandemic.